✨ Amendment to Pharmaceutical Payment Notices
27 APRIL NEW ZEALAND GAZETTE 983
-
The Southern Notice is amended by:
a) Deleting clause G2 and replacing it with the following:
“G2 Data Definition
You agree to ensure that whenever information systems operated by you incorporate data required by the national health system, the data definitions used by you correspond directly with Pharmaceutical Transactions Data Specification Version 2.7 set out as an Appendix to this Notice.”
b) Adding the Appendix set out in the Schedule to this Agreement as an Appendix to the Notice.
SCHEDULE
“Appendix Pharmaceutical Transactions Data Specification Version 2.29.”
Explanatory Note
Some pharmacists who claim payment for various pharmacy services from the Ministry of Health are paid for those services according to the terms of Notices issued under section 51 of the Health and Disability Services Act 1993, and continued by the New Zealand Public Health and Disability Act 2000. Among other things, section 88 (3) of that Act requires all amendments to the Notice to be published in the Gazette. This Amendment No. 1 makes changes to the data specifications which Pharmacists claiming under those Notices are required to supply to the Ministry of Health.
Two different Notices are amended here. The first is the Notice applying to Pharmacists in the Southern region which was issued by the Southern Regional Health Division of the Transitional Health Authority under section 51 of the Health and Disability Services Act 1993. The second is the Triple Region Notice which was given almost one year later by the Health Funding Authority to pharmacists in the Northern, Midland and Central Regions. Pharmacists in the Southern Region were not consulted when the Triple Region Notice was issued because the Southern Region was already covered by the Southern Notice. Consequently, different terms and conditions are contained in the two Notices. This Amendment No. 1 requires pharmacists covered by both Notices to provide data according to the same data specifications.
This explanation is given to meet the requirements of section 89 (5) of the New Zealand Public Health and Disability Act.
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 44
Gazette.govt.nz —
NZ Gazette 2001, No 44
✨ LLM interpretation of page content
🏥
Amendment to Pharmaceutical Payment Notices
(continued from previous page)
🏥 Health & Social WelfareAmendment, Pharmaceutical Notices, Health Funding Authority, Transitional Health Authority, Data Specification